AVBP
ArriVent BioPharma, Inc.
16.70$
-1.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.9% | 98.1% | 99.9% | 99.9% | 99.9% | 82.6% | 86.2% | 92.8% | 98.4% | 99.9% | 99.8% | 99.9% | |
| 77.7% | 92.2% | 96.8% | 96.7% | 96.6% | 27.0% | 23.1% | 41.8% | 34.5% | 13.7% | 17.8% | 39.2% | |
| 91.4% | 92.2% | 96.8% | 96.7% | 96.6% | 79.6% | 81.7% | 87.5% | 91.9% | 93.9% | 93.4% | 94.5% | |
| 0.6% | 0.5% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.0% | – | – | |
| 5.5% | 7.2% | 3.1% | 3.9% | 5.2% | 6.3% | 6.0% | 7.3% | 6.6% | 7.8% | 7.2% | 7.1% | |
| 5.5% | 7.1% | 3.0% | 3.9% | 5.2% | 6.3% | 6.0% | 7.3% | 6.6% | 7.8% | 7.2% | 7.1% | |
| 0.0% | 0.1% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | |
| 2.6% | 2.8% | 1.3% | 1.2% | 1.6% | 1.4% | 2.0% | 1.5% | 1.8% | 1.8% | 2.5% | 0.6% | |
| 94.5% | 92.8% | 96.9% | 96.1% | 94.8% | 93.7% | 94.0% | 92.7% | 93.4% | 92.2% | 92.8% | 92.9% | |
| -75.1% | -96.8% | -53.5% | -63.8% | -74.4% | -86.7% | -140.5% | -124.0% | -113.0% | -121.5% | -128.2% | -126.1% | |
| 18.4% | 20.5% | 10.2% | 10.8% | 11.5% | 12.2% | 15.7% | 13.0% | 12.8% | 11.5% | 12.9% | 12.1% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.